Published March 2026

How Suboxone Film Destroys Tooth Enamel: The Science

Last updated: May 2026

The dental injuries linked to Suboxone sublingual film are not random, not a coincidence, and not the patient's fault. They are the predictable result of a specific chemical mechanism that the film's manufacturers understood from the product's inception. Here is the science.

Tooth Enamel: The Body's Hardest Tissue — and Its Achilles Heel

Tooth enamel is the hardest substance in the human body. It is composed primarily of hydroxyapatite — a crystalline calcium phosphate mineral — arranged in highly organized rods. Enamel has no living cells and cannot regenerate once destroyed. Its strength comes from its mineral density, but that same mineral composition makes it vulnerable to one thing: acid.

Hydroxyapatite dissolves in acidic environments through a process called demineralization. The critical pH threshold — the point at which enamel begins to dissolve in contact with an acidic substance — is approximately 5.5. Below pH 5.5, enamel demineralizes. The lower the pH, the faster and more aggressive the demineralization.

Suboxone Film's pH: 3.4

Suboxone sublingual film has a measured pH of approximately 3.4. This is more than 100 times more acidic than the enamel demineralization threshold of 5.5 (because pH is a logarithmic scale). For comparison:

• White vinegar: pH 2.4
• Orange juice: pH 3.5
• Suboxone film: pH ~3.4
• Black coffee: pH 5.0
• Enamel demineralization threshold: pH 5.5
• Pure water: pH 7.0

Suboxone film is, in terms of enamel damage potential, roughly equivalent to soaking your teeth in orange juice — for 5–15 minutes per dose, every day, for years.

The Mechanism: What Happens With Every Dose

When a patient places Suboxone film under or on their tongue, the film begins dissolving immediately. Over 5–15 minutes, it produces an acidic solution that pools in the floor of the mouth and contacts the lingual (tongue-side) surfaces of the lower teeth and the palatal surfaces of the upper teeth — areas that are normally protected by saliva neutralization.

During this dissolution period:

• The acidic film solution contacts enamel surfaces at pH ~3.4
• Hydroxyapatite crystals begin dissolving on contact
• Calcium and phosphate ions are leached from the enamel surface
• The enamel surface softens — becoming vulnerable to abrasion and further acid attack
• Saliva begins working to re-mineralize the surface, but may not fully neutralize the acid before the next dose

This process repeats every day. Often twice a day. For months or years at a time.

The Compounding Effect of Buprenorphine on Dry Mouth

Buprenorphine — the active medication in Suboxone — independently contributes to dental damage through a second mechanism: xerostomia (dry mouth). Buprenorphine and other opioids reduce saliva production by acting on muscarinic receptors in salivary gland tissue.

Saliva is critical to dental health. It buffers acid, delivers remineralizing calcium and phosphate, and physically washes debris from tooth surfaces. When saliva production is reduced, the mouth's natural defense system against acid attack is compromised. Patients taking Suboxone are simultaneously exposing their teeth to a highly acidic film AND reducing their mouth's natural defenses against that acid.

Why Enamel Loss Is Permanent

Unlike bone, which can remodel and partially heal, tooth enamel contains no living cells. Once enamel is dissolved, it cannot be regenerated by the body. Fluoride can help remineralize enamel at the surface level under mild acid conditions, but it cannot repair structural enamel loss from prolonged severe acid exposure.

This means that every dose of Suboxone film causes a small, permanent reduction in enamel thickness. Over months and years, this cumulative loss crosses a threshold where teeth become structurally compromised — soft, discolored, prone to fracture, and increasingly susceptible to bacterial decay in the demineralized surface.

The Manufacturer Knew

The acidic pH of Suboxone film is a property of its formulation — polymer matrix, preservatives, and other excipients — not of the active buprenorphine ingredient. This formulation was designed, tested, and approved by the manufacturer. The pH of the final product was measurable and measured during development. The damage potential to tooth enamel from a prolonged-contact oral product at pH 3.4 is basic biochemistry — it was not a hidden finding waiting to be discovered.

Adverse event reports of dental damage began accumulating in pharmacovigilance databases well before the 2022 FDA warning. The litigation against Indivior PLC and Aquestive Therapeutics centers on the allegation that the manufacturers had this knowledge and failed to warn patients.